Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan
- 1 June 1999
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 34 (2), 123-134
- https://doi.org/10.1016/s0732-8893(99)00019-x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- A Randomized, Double-blind Clinical Trial Comparing Cefepime Plus Metronidazole With Imipenem-Cilastatin in the Treatment of Complicated Intra-abdominal InfectionsArchives of Surgery, 1997
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United StatesThe Journal of Infectious Diseases, 1994
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994
- CefepimeDrugs, 1994
- International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- PCR buffer optimization with uniform temperature regimen to facilitate automation.Genome Research, 1993
- Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1992
- In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitorAntimicrobial Agents and Chemotherapy, 1989